ArticleResearch square2026

Poly-Pharmacologic Disruption of the Proliferative-to-Mesenchymal Fate Branch Point Reverses EndMT and Pulmonary Hypertension.

Dinesh Bharti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.